Literature DB >> 9498461

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

D A Jabs1, C Enger, J P Dunn, M Forman.   

Abstract

Cytomegalovirus (CMV) retinitis is among the most common opportunistic infections in patients with AIDS and a substantial cause of visual loss. With long-term therapy, resistant CMV may develop. In a prospective study of 108 patients with CMV retinitis, 80.6% of patients were found to have either a positive blood culture or positive urine culture for CMV at the diagnosis of retinitis. At diagnosis of retinitis, 0.9% and 2.7% of patients had a ganciclovir-resistant blood culture isolate and urine culture isolate, respectively. Of 76 patients initially treated with ganciclovir, 11.4% had a resistant blood or urine culture isolate by 6 months of treatment and 27.5% by 9 months. The development of ganciclovir resistance during follow-up correlated with the occurrence of CMV retinitis in the contralateral eye (odds ratio = 9.06, P = .003).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498461     DOI: 10.1086/514249

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Limitations of cytomegalovirus testing.

Authors:  J Harmenberg; M Brytting
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.

Authors:  N K Bakshi; G A Fahle; I Sereti; H Wiley; R B Nussenblatt; H N Sen
Journal:  Eye (Lond)       Date:  2012-02-10       Impact factor: 3.775

3.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

Review 4.  Human cytomegalovirus resistance to antiviral drugs.

Authors:  C Gilbert; G Boivin
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  A case report of CMV lymphadenitis in an adult kidney transplant recipient.

Authors:  E L Lum; J M Schaenman; M DeNicola; U G Reddy; J I Shen; S T Pullarkat
Journal:  Transplant Proc       Date:  2015 Jan-Feb       Impact factor: 1.066

6.  Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.

Authors:  Gyu-Cheol Lee; Dong-Gun Lee; Su-Mi Choi; Jin-Hong Yoo; Sun-Hee Park; Jung-Hyun Choi; Woo-Sung Min; Ok-Hee Cho; Chan-Hee Lee; Wan-Shik Shin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

7.  Drug-resistant herpesviruses: should we look for them?

Authors:  G Boivin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

8.  Therapy and Prevention of Cytomegalovirus Retinitis.

Authors:  Asok Kurup; Francesca J. Torriani
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

9.  Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication.

Authors:  George W Koszalka; Nelson W Johnson; Steven S Good; Leslie Boyd; Stanley C Chamberlain; Leroy B Townsend; John C Drach; Karen K Biron
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Optimal management of cytomegalovirus retinitis in patients with AIDS.

Authors:  Michael W Stewart
Journal:  Clin Ophthalmol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.